Bausch & Lomb is the preeminent global technology based healthcare company for the eye, dedicated to helping consumers see, look and feel better through innovative technology and design. The company is building on that position through expansion of its current eye care businesses, as well as the pursuit of promising new opportunities within the global eye care market.
Bausch & Lomb manages its commercial operations on a regional basis and the research and development and product supply functions are managed on a global basis. The company markets five broad categories of products:
Contact Lenses: Sales of contact lenses represented approximately 28% of consolidated 2001 revenues. The company's contact lens offerings span the entire spectrum of wearing modalities and include such well known brand names as PureVision, SofLens66 Toric, SofLens One Day, Bausch & Lomb Two Week, Boston and Optima FW.
Lens Care: The sale of contact lens care solutions represented approximately 25% of consolidated 2001 revenues. The company’s lens care products include the ReNu and Sensitive Eyes brands for soft contact lenses and the Boston line of products for cleaning rigid gas permeable contact lenses.
Cataract and Vitreoretinal Surgery: Products used for cataract and vitreoretinal surgery procedures accounted for approximately 18% of consolidated 2001 revenues. The company offers a full suite of products in this area, including various intraocular lenses and delivery systems, the Millennium line of phacoemulsification equipment, and other surgical devices and instruments.
Refractive Surgery: Sales of products used in refractive surgery accounted for approximately 8% of consolidated 2001 revenues. Offerings in this area include the Technolas 217 small-beam advanced scanning excimer laser, the Hansatome microkeratome, the Orbscan corneal topographer and, outside the U.S., the Zyoptix system for customized laser vision correction.
Pharmaceutical: Sales of pharmaceutical products accounted for approximately 21% of consolidated 2001 revenues. The company’s offerings include generic and proprietary prescription pharmaceuticals, mostly in the ophthalmic field, over-the-counter eye drops and other medications. During 2000 the company expanded its presence in this area through the acquisition of Groupe Chauvin, a French ophthalmic pharmaceutical company. In combination with the company's existing Dr. Mann Pharma business in Germany, the acquisition will provide a pan-European presence and infrastructure from which to launch new products in development as well as to expand the distribution of the company's current proprietary pharmaceutical products, such as Lotemax and Alrex.
| Contact Details: |
| One Bausch & Lomb Place |
| Rochester |
| NY |
| 14604 |
| United States of America |
| Tel: | 716 338 6000 |
| Fax: | |
| Email: | |
| WWW: | www.bausch.com/
|
|
Loading...
|
Recent Publications by Bausch & Lomb Incorporated: |  |
Sacral nerve stimulation in patients with severe constipation.
PURPOSE: Constipation is frequently a multifactorial disease. This study... | 2nd July, 2008
| Surgical Department, Danube Hospital-SMZ-Ost, Vienna, Austria.
| Dis Colon Rectum. 2008 May;51(5):524-29; discussion 529-30. Epub 2008 Mar
DOI Direct Link |
Immunomagnetic CD45 depletion does not improve cytokeratin 20 RT-PCR in colorectal cancer.
BACKGROUND: Cytokeratin 20 reverse transcriptase polymerase chain reaction... | 20th July, 2007
| Department of Surgery, Ludwig Boltzmann Research Institute of Surgical
| Clin Chem Lab Med. 2007;45(3):351-6.
DOI Direct Link |
Sacral nerve stimulation for neurogenic faecal incontinence.
BACKGROUND: Sacral nerve stimulation (SNS) has emerged as a promising... | 29th June, 2007
| Department of Surgery, Danube Hospital, Sozialmedizinisches Zentrum Ost,
| Br J Surg. 2007 Jun;94(6):749-53.
DOI Direct Link |
Aetiology and surgical management of toxic megacolon.
OBJECTIVE: The purpose of this article is to review the surgical... | 14th July, 2006
| Department of Surgery, Danube Hospital, and Department of General Surgery,
| Colorectal Dis. 2006 Mar;8(3):195-201.
DOI Direct Link |
Improving the safety of laparoscopic cholecystectomy: the routine use of preoperative magnetic resonance cholangiography.
BACKGROUND: The aim of this study was to determine the value of routinely... | 6th May, 2006
| Department of Surgery, Danube Hospital, SMZ-Ost, Langobardenstrasse 122,
| Surg Endosc. 2005 Apr;19(4):574-80. Epub 2005 Mar 11.
DOI Direct Link |
→View more Bausch & Lomb Incorporated research publications. |
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 241 times since April 2007, the link to the organisation's website has been followed 50 times
Recent Search Terms used to find this page: bausch.com | .
Search for more companies in Rochester
Search for more companies in NY
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
Bausch & Lomb Incorporated
